COVID-19變種病毒加護病房病危個案中醫介入治療病例報告

Traditional Chinese Medicine as interventional treatment to care a critically ill case of COVID-19 variant virus in intensive care unit -A Case Report

蘇郁婷(Yu-Ting Su) ； 龔彥穎(Yen-Ying Kung) ； 陳方佩(Fang-Pey Chen) ； 張凱惟(Kei-Wei Chang)

《北台灣中醫醫學雜誌》 15卷1期 (2023/03) Pp. 33-51

摘要

2022年COVID-19變種病毒Omicron開始於臺灣各地爆發並迅速流行，多數感染者為無症狀或症狀輕微，但對於年長者卻是一大威脅，往往迅速轉成重症，甚至是危重症，死亡率極高。本病例為高齡92歲女性，罹患COVID-19變種病毒後，約3天內轉成重症進入加護病房，經西醫救治後仍面臨瀕死狀態並發布病危通知，家屬尋求中醫介入治療後，病情逐漸穩定並順利出院返家休養，藉由本病例之中西醫結合治療過程與用藥思維，提供中醫師研究與參考。

關鍵字

COVID-19 ； Omicron ； 病危 ； 中西醫

並列摘要

In 2022, the Omicron variant of COVID-19 began to break out and spread rapidly in various parts of Taiwan. Most infected people were asymptomatic or had mild symptoms, while it was a big threat to the elderly. The condition of elderly infected people tended to deteriorate rapidly and even became critically ill rapidly; besides, the mortality rate was extremely high. This case was a 92-year-old woman. She was transferred to the intensive care unit within about 3 days after suffering from the COVID-19 variant virus. Even received Western medicine treatment continuing, she was still facing a dying state and a critical illness notice was issued. After her family members sought interventional treatment from traditional Chinese medicine, her condition gradually stabilized. Finally, she discharged from the hospital successfully and returned home to recuperate. This case study provided the treatment process and medication thinking of integrated traditional Chinese medicine and Western medicine for Chinese medical physicians.

並列關鍵字

COVID-19 ； Omicron ； Critical illness ； traditional Chinese medicine and Western Medicine

參考文獻

Arora, S., et al., Literature Review of Omicron: A Grim Reality Amidst COVID-19. Microorganisms, 2022. 10(2).

Cao, Y., et al., BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature, 2022. 608(7923): p. 593-602.

張金堅，許辰陽，賴昭智，許文峰，廖思涵，林世斌，趙從賢，任小萱，彭思敏，陳秀熙 , 新冠肺炎 （COVID-19） 的免疫學探討。 臺灣醫界 , 2020. 63(10)：13-26.

Kario, K., et al., COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich), 2020. 22(7): p. 1109-1119.

Lu, P.-H., et al., Jing Si Herbal Drink as a prospective adjunctive therapy for COVID-19 treatment: Molecular evidence and mechanisms. Pharmacological Research - Modern Chinese Medicine, 2022. 2.